Abdul A. Baba
Kuala Lumpur, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Dysregulation of Ceruloplasmin, α2-Macroglobulin, and Alpha-2-HS-Glycoprotein in Transfusion-Dependent Thalassemia.
Journal: Advances in hematology
Published: November 15, 2023
A Novel Method to Identify Autoantibodies against Putative Target Proteins in Serum from beta-Thalassemia Major: A Pilot Study.
Journal: Biomedicines
Published: March 23, 2020
Genetic variations in influx transporter gene SLC22A1 are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients.
Journal: Journal of genetics
Published: September 29, 2018
Pharmacogenetics and the treatment of chronic myeloid leukemia: how relevant clinically? An update.
Journal: Pharmacogenomics
Published: March 24, 2018
Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients.
Journal: Cancer reports (Hoboken, N.J.)
Published: January 02, 2018
Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients.
Journal: Cardiovascular & hematological disorders drug targets
Published: December 07, 2017
Association of GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms with clinical response to imatinib mesylate treatment among Malaysian chronic myeloid leukaemia patients.
Journal: Journal of genetics
Published: September 27, 2017
Review: Beta-thalassemia and molecular chaperones.
Journal: Blood cells, molecules & diseases
Published: November 15, 2014
BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome.
Journal: Leukemia research
Published: October 13, 2013
The impact of medical education on psychological health of students: a cohort study.
Journal: Psychology, health & medicine
Published: November 13, 2012
HOXA4 gene promoter hypermethylation as an epigenetic mechanism mediating resistance to imatinib mesylate in chronic myeloid leukemia patients.
Journal: BioMed research international
Published: October 04, 2012
Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients.
Journal: Hematology reports
Published: July 23, 2012
Last Updated: 09/26/2026